24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
ADHD
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
08:16
Stanley Fischer, former Bank of Israel Governor and US Fed Vice Chair, dies at 81
18:00
Israeli AI startup REplace raises $2.1M to accelerate clean energy deployment with site selection platform
15:35
Telegram's $1.745 billion bond sale severely oversubscribed
15:15
Empathy raises $72M Series C to streamline grief support and estate management
More stories
Buzz
Most popular
Daily
Weekly
1
Tenable acquires Sam Altman-backed Apex for over $105 million to boost AI security
2
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
3
Buildots raises $45M at $300M valuation to modernize global construction with AI
4
Guardicore founders raise $32 million for new stealth cyber-AI startup
5
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
More news
ADHD
4 stories about ADHD
“There are so few female founders; this has to be put in the past”
21.08.24
|
Ariela Karmel
Eve Mamane, Co-Founder and CRO of mental health startup Agave Health, spoke to CTech about founding her first venture, the need to normalize female founders, and why the tech industry must eliminate outdated limitations on women in leadership roles
Israeli app launches in the U.S. and Israel, helping parents of ADHD children
15.01.24
|
James Spiro
Pery uses clinical data and LLMs to provide advice and analysis for parents managing children diagnosed with attention deficit hyperactivity disorder
“There is a $5 billion opportunity in the ADHD market”
30.01.23
|
CTech
MindTension has raised a total of $2 million for its tool helping diagnose and treat optimization of ADHD and related mental health comorbidities
Teva Reaches Confidential Patent Settlement with Neos
27.12.18
|
CTech
The agreement will enable Teva to manufacture and sell a generic version of Neos’ ADHD drug Cotempla as of 2026